Tech Innovator Profile – Verge Genomics
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Verge Genomics is an AI-driven biopharmaceutical drug discovery company which applies patient genomes, epigenomics, and gene expression for identifying novel effective drugs, stratify patient subpopulations, and therapeutic gene targets for accelerating clinical success.
Scope
The report provides information and insights into Verge Genomics's, including –
– Overview of the company and its product offering
– Detailed insight into its business model, company type and headquarter
– Information on funding
– Biography of top management
Reasons to Buy
– Gain insights into Verge’s business operations.
– Gain insights into funding and partnerships
– Gain understanding about its technology focus.
Datavant
Massachusetts General Institute for Neurodegenerative Disease
Motor Neuron Center at Columbia University
Keck School of Medicine
Two Sigma Ventures
Slow Ventures
Refactor Capital
OS Fund
Karlin Ventures
IA Ventures
Great Oaks Venture Capital
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Technology reports